Heplisav-B (hepatitis B vaccine (recombinant), adjuvanted) / Dynavax, Bavarian Nordic  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Heplisav-B (hepatitis B vaccine (recombinant), adjuvanted) / Dynavax
BEe-HIVe, NCT04193189: B-Enhancement of HBV Vaccination in Persons Living With HIV (): Evaluation of HEPLISAV-B

Active, not recruiting
3
640
US, RoW
HEPLISAV-B, ENGERIX-B
National Institute of Allergy and Infectious Diseases (NIAID), Dynavax Technologies Corporation
HIV Infection, Hepatitis B
07/24
07/24

Download Options